Literature DB >> 1697561

Homologous species restriction of the complement-mediated killing of nucleated cells.

H Yamamoto1, P Blaas, A Nicholson-Weller, G M Hänsch.   

Abstract

The homologous restriction of complement (C) lysis is attributed to membrane proteins: decay-accelerating factor (DAF), C8 binding protein (C8bp) and P18/CD59. Since these proteins are also expressed on peripheral blood cells, species restriction was tested for in the complement-mediated killing of antibody-coated human leucocytes by human or rabbit complement. Killing was more efficient when rabbit complement was used. Preincubation of cells with an antibody to DAF abolished the difference. When C1-7 sites were first attached to the cells and either rabbit or human C8, C9 were added, the killing of monocytes and lymphocytes was equally efficient; only in polymorphonuclear neutrophils was a higher efficiency of rabbit C8, C9 seen. Thus, in contrast to haemolysis, restriction occurred predominantly at the C3 level and the action of the terminal complement components was not inhibited. Since C8bp isolated from peripheral blood cells showed essentially similar characteristics as the erythrocyte-derived C8bp, the failure of C8bp to inhibit the action of the terminal components on nucleated cells might reflect differences of the complement membrane interactions between erythrocytes or nucleated cells, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697561      PMCID: PMC1384243     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.

Authors:  L S Zalman; L M Wood; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Effect of osmotic protection on nucleated cell killing by C5b-9: cell death is not affected by the prevention of cell swelling.

Authors:  S H Kim; D F Carney; J C Papadimitriou; M L Shin
Journal:  Mol Immunol       Date:  1989-03       Impact factor: 4.407

3.  A cytotoxic antiglobulin technique for assay of antibodies to histocompatibility antigens.

Authors:  L Fass; R B Herberman
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

4.  Homologous species restriction in lysis of erythrocytes by terminal complement proteins.

Authors:  G M Hänsch; C H Hammer; P Vanguri; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

5.  The eighth component of human complement. Purification and physicochemical characterization of its unusual subunit structure.

Authors:  E W Steckel; R G York; J B Monahan; J M Sodetz
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

6.  Release of C8 binding protein (C8bp) from the cell membrane by phosphatidylinositol-specific phospholipase C.

Authors:  G M Hänsch; P F Weller; A Nicholson-Weller
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

7.  A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement.

Authors:  N Okada; R Harada; T Fujita; H Okada
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

8.  CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

Authors:  A Davies; D L Simmons; G Hale; R A Harrison; H Tighe; P J Lachmann; H Waldmann
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  Interaction of histocompatibility (HL-A) antibodies and complement with synchronized human lymphoid cells in continuous culture.

Authors:  S Ferrone; N R Cooper; M A Pellegrino; R A Reisfeld
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

View more
  4 in total

1.  Absence of CD59 in Guinea Pigs: Analysis of the Cavia porcellus Genome Suggests the Evolution of a CD59 Pseudogene.

Authors:  Hani Boshra; Wioleta M Zelek; Timothy R Hughes; Santiago Rodriguez de Cordoba; B Paul Morgan
Journal:  J Immunol       Date:  2017-11-22       Impact factor: 5.422

Review 2.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.

Authors:  C L Harris; O B Spiller; B P Morgan
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

Review 4.  Subversion of complement by hematophagous parasites.

Authors:  Hélène Schroeder; Patrick J Skelly; Peter F Zipfel; Bertrand Losson; Alain Vanderplasschen
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.